Gould Capital »

Neurocrine Biosciences shares owned by Gould Capital

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Gould Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 9.4k 168.54

More positions owned by Gould Capital

Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total Bond Market Etf Etf (BND)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total International Bond Etf Etf (BNDX)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Apple Stock (AAPL)
Spdr Gold Shares Etf (GLD)
Microsoft Corp Stock (MSFT)
Verizon Communications Stock (VZ)
Union Pac Corp Stock (UNP)
Merck & Co Stock (MRK)
Starbucks Corp Stock (SBUX)
Public Storage Reit (PSA)
Coca Cola Stock (KO)
Costco Wholesale Corporation Stock (COST)

View all positions for Gould Capital

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences